15 nowych badań

Zaktualizowano listę badań klinicznych w poszczególnych ankietach ewaluacyjnych, dodając do wybranych ankiet następujące badania: 
- PATH-HOME (Tezepelumab Home Use Study)
Choroba Leśniowskiego-Crohna:
- VIVID-1 (A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease)
Choroba zwyrodnieniowa stawów:
- FACT LTS & OA (Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip);
- SpaTreat (Effectiveness of Spa Treatment, Outpatient Physiotherapy and no Physiotherapy in Spine Osteoarthritis); 
- ArthSpec (Study to Evaluate Arthroplasty Specimens for Osteoarthritis of the Knee and Hip) 
- INNODIA (An Innovative Approach Towards Understanding and Arresting Type 1 Diabetes);
- 287/Glarg (A Research Study to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine in People With Type 2 Diabetes  Who Have Not Used Insulin Before);
- REX-001(4) (The Efficacy and Safety of REX-001 to Treat Ischemic Rest Pain in Subjects With CLI Rutherford Category 4 and DM);
- REX-001(5) (The Efficacy and Safety of REX-001 to Treat Ischemic Ulcers in Subjects With CLI Rutherford Category 5 and DM); 
- FOCUS (A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes)
- OphtOSA (Long-term Observation of Ophthalmic Changes in Patients With Obstructive Sleep Apnea)
Łuszczyca i Łuszczycowe zapalenie stawów:
- IMPACT-PS (Study to Evaluate the Efficacy and Safety of JTE-451 in Subjects With Moderate to Severe Plaque Psoriasis)
Nadciśnienie płucne:
- BNP-PL (DataBase of pulmoNary hyPertesion in PoLish Population - BNP-PL);
- REPLACE (Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapy);
- SelexipagPedPH (A Clinical Study of to Confirm the Doses of Selexipag in Children With Pulmonary Arterial Hypertension)